DSIP is a nine-residue peptide first characterized in cross-circulation and EEG model systems in the late 1970s. In research-use-only contexts, it is best discussed as a reference material for CNS signaling, delta-wave EEG studies, HPA-axis experiments, peptide transport, neuroendocrine assays, and oxidative-stress model work.
This compound is supplied exclusively for in vitro and preclinical research. It is not intended for human consumption, therapeutic application, diagnostic use, or clinical use.
Background in Delta-Wave EEG Models
The original Schoenenberger and Monnier work used rabbit cross-circulation, low-molecular-weight blood fractions, peptide isolation, and EEG monitoring. A purified nonapeptide fraction was associated with delta-wave EEG changes in recipient animals, leading to the DSIP designation.
Later studies treated DSIP as a tool compound for examining CNS peptide signaling rather than as a consumer-directed outcome claim. That distinction matters for RUO copy: the appropriate focus is the model system, analyte, pathway, and study design.
Research Areas
Published DSIP literature commonly clusters around several preclinical and analytical themes:
- EEG model systems – studies using delta-wave activity, REM/NREM staging, and related electrophysiology endpoints.
- CNS peptide transport – experiments evaluating whether DSIP crosses the blood-brain barrier through saturable transport processes.
- HPA-axis assays – animal studies measuring corticosterone, cortisol-analog endpoints, and other neuroendocrine markers under controlled laboratory conditions.
- Pituitary-hormone research – investigations into LH, GH, and other pituitary signaling patterns in preclinical models.
- Oxidative-stress models – cell-culture and animal-model work tracking glutathione, lipid peroxidation, and enzyme-activity markers.
Mechanistic Questions
Graf and Kastin reported evidence that DSIP can cross the blood-brain barrier through a saturable transport system. That finding made DSIP useful for peptide-transport literature because it suggested more than passive diffusion in the CNS compartment.
At the same time, DSIP remains mechanistically unsettled. No specific receptor has been definitively assigned, plasma stability is limited, and published results vary by model, timing, analytical endpoint, and peptide preparation.
HPA-Axis and Neuroendocrine Literature
Several research groups have evaluated DSIP in HPA-axis and neuroendocrine experiments. These papers generally measure laboratory markers such as corticosterone, cortisol-related endpoints, feeding-pattern observations, and pituitary-hormone changes in animal models.
For compliance-safe product education, those studies should be framed as pathway and assay literature. The copy should avoid presenting DSIP as a solution for a person, condition, symptom, or consumer goal.
Oxidative-Stress Model Work
Bondarenko and colleagues described DSIP activity in oxidative-stress model systems. The reported endpoints included glutathione levels, lipid peroxidation markers, and antioxidant-enzyme activity in cell-culture and animal-model settings.
These findings are best treated as assay observations, not as health or outcome claims. They provide context for researchers comparing DSIP with other CNS and neuroendocrine peptide materials.
Research Limitations
- Unassigned receptor: DSIP does not yet have a settled receptor target, which keeps mechanism-of-action work open.
- Stability questions: The peptide is susceptible to enzymatic degradation, making sample handling and analog design relevant research variables.
- Replication pattern: A meaningful share of the older literature comes from a limited set of research groups, so independent replication remains important.
Product Specifications
- Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
- Molecular Weight: 848.82 g/mol
- CAS Number: 62568-57-4
- Physical Form: Sterile lyophilized white powder
- Purity: 99%+ by HPLC
Key References
- Schoenenberger GA, Monnier M. 1977 PNAS DSIP characterization paper.
- Graf MV, Kastin AJ. 1984 neuroscience review of DSIP transport and preclinical literature.
- Sudakov KV, et al. 1995 New York Academy of Sciences paper on DSIP and laboratory HPA-axis models.
- Bondarenko TI. 2004 paper on DSIP molecular activity in oxidative-stress model systems.
For batch documentation, review the DSIP COA entry in the Chameleon Peptides testing archive. DSIP materials are offered for laboratory research use only.